rss
Br J Ophthalmol 88:1107-1112 doi:10.1136/bjo.2003.023986
  • Value based ophthalmology

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case

Table 4

 Sensitivity analysis

Cost per QALY, 5 year time frame, cohort with best corrected visual acuity = 20/40 (in £000)
Values Government perspective PDT cost only
Base case 9 38
Government perspective, low estimate £1325/year 32 NA
Angiogram follow up* £2640 (angiogram+outpatient visit every 3 months after PDT treatment ends) 24 54
Cost per QALY, 5 year time frame, cohort with best corrected visual acuity = 20/100 (in £000)
Values Government perspective PDT cost only
*In the base case, it is assumed that an angiogram is used for follow up only during the course of treatment. This sensitivity analysis assumes PDT treated patients have an angiogram and outpatient visit every 3 months for the entire period of the model for follow up, regardless of whether or not PDT is being given. This is in addition to standard follow up being done for non-PDT treated patients.
Base case 30 69
Government perspective, low estimate £1325/year 61 NA
Angiogram follow up* £2640 (angiogram+outpatient visit every 3 months after PDT treatment ends) 58 97

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.